Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.8445
-0.0155 (-1.80%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $30.56 million as of March 24, 2026. Its market cap has decreased by -28.76% in one year.
Market Cap
30.56M
Enterprise Value
26.69M
1-Year Change
-28.76%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $30.56M, a decrease of -67.76%. That is a compound annual growth rate of -15.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 31.10M | -8.53% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 33.77M |
| Serina Therapeutics | 33.59M |
| Jasper Therapeutics | 33.30M |
| INmune Bio | 32.97M |
| Tiziana Life Sciences | 32.08M |
| Rein Therapeutics | 31.28M |
| ABVC BioPharma | 31.04M |
| Pluri | 30.76M |